We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+8.86%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.03B
AUM Growth
+$37.3M
Cap. Flow
-$165M
Cap. Flow %
-5.47%
Top 10 Hldgs %
10.89%
Holding
446
New
42
Increased
142
Reduced
204
Closed
38

Sector Composition

Rank Sector Weight
1 Financials 18.48%
2 Technology 14.71%
3 Industrials 14.65%
4 Consumer Discretionary 11.24%
5 Healthcare 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBG
351
DELISTED
Everbridge, Inc. Common Stock
EVBG
$1.05M 0.03%
+13,420
New +$1.04M
HUBS icon
352
HubSpot
HUBS
$10.5B
$997K 0.03%
6,290
-7
-0.1% -$1.07K
SRPT icon
353
Sarepta Therapeutics
SRPT
$1.77B
$978K 0.03%
7,576
-834
-10% -$84.2K
BPMC
354
DELISTED
Blueprint Medicines
BPMC
$962K 0.03%
12,004
-11,771
-50% -$881K
KBH icon
355
KB Home
KBH
$3.59B
$934K 0.03%
+27,262
New +$942K
LAD icon
356
Lithia Motors
LAD
$8.26B
$932K 0.03%
+6,341
New +$953K
WBS icon
357
Webster Financial
WBS
$12.8B
$926K 0.03%
17,346
-17,261
-50% -$830K
CHRS icon
358
Coherus Oncology
CHRS
$196M
$924K 0.03%
51,319
-104,762
-67% -$1.93M
LHCG
359
DELISTED
LHC Group LLC
LHCG
$915K 0.03%
6,642
-6,507
-49% -$810K
RBC icon
360
RBC Bearings
RBC
$18B
$892K 0.03%
5,633
-5,524
-50% -$893K
MYOK
361
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$839K 0.03%
+11,516
New +$699K
CCXI
362
DELISTED
ChemoCentryx, Inc.
CCXI
$827K 0.03%
+20,916
New +$367K
PD icon
363
PagerDuty
PD
$902M
$820K 0.03%
+35,054
New +$862K
SYK icon
364
Stryker
SYK
$130B
$814K 0.03%
+3,879
New +$805K
BB icon
365
BlackBerry
BB
$5.26B
$809K 0.03%
125,943
-2,260
-2% -$12.4K
SILK
366
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$758K 0.03%
+18,760
New +$657K
VCEL icon
367
Vericel Corp
VCEL
$2.31B
$742K 0.02%
42,658
-41,829
-50% -$712K
ARES icon
368
Ares Management
ARES
$30.9B
$738K 0.02%
+20,683
New +$643K
IQV icon
369
IQVIA
IQV
$39.3B
$736K 0.02%
4,765
NBIX icon
370
Neurocrine Biosciences
NBIX
$16.6B
$690K 0.02%
6,418
FISV
371
Fiserv Inc
FISV
$27.9B
$646K 0.02%
+5,589
New +$617K
CSTL icon
372
Castle Biosciences
CSTL
$979M
$645K 0.02%
18,755
-18,400
-50% -$450K
SAGE
373
DELISTED
Sage Therapeutics
SAGE
$643K 0.02%
8,908
+4,045
+83% +$498K
TDG icon
374
TransDigm Group
TDG
$67.7B
$626K 0.02%
1,118
-150
-12% -$82.1K
AA icon
375
Alcoa
AA
$13.2B
$609K 0.02%
28,323
-33,744
-54% -$699K

Similar funds

Chartwell Investment Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Chartwell Investment Partners held 446 positions worth $3.03B, up 1.2% from $2.99B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Chartwell Investment Partners withdrew a net $165M in Q4 2019, closing 38 positions and reducing 204 holdings. Its most notable exit was SunTrust Banks, Inc., an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in Moog Inc Class A worth $16.3M.

  • Chartwell Investment Partners's largest Q4 2019 buy was Moog Inc Class A: 190,804 shares worth $16.3M.
  • Chartwell Investment Partners added most to Truist Financial in Q4 2019, an estimated $13M increase.
  • Chartwell Investment Partners's biggest Q4 2019 reduction was Pfizer, cutting an estimated $18.8M.
  • Chartwell Investment Partners fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $12.3M.
  • Chartwell Investment Partners's ten largest holdings make up 11% of its $3.03B portfolio in Q4 2019.
  • Chartwell Investment Partners opened 42 new positions and closed 38 in Q4 2019.
  • Chartwell Investment Partners's portfolio value rose 1.2% quarter-over-quarter to $3.03B.

Based on Chartwell Investment Partners's 13F filing for Q4 2019, filed 29 Jan 2020.